A single-nucleotide polymorphism of GRIN1 in heroin and methamphetamine addicts at a rehabilitation sanatorium in Markazi province, Iran

Author(s):
Ahmad HamtaAhmad Hamta1,*, Maryam sahraeiMaryam sahraei1
1Dept. of Biology, Faculty of Science, Arak University, Arak, Iran
*Corresponding Author: Corresponding author: Ahmad Hamta, Dept. of Biology, Faculty of Science, Arak University, Arak, Iran, Tel: +98 9183671016 Email: [email protected]

Journal of Kermanshah University of Medical Sciences:Vol. 20, issue 4; e69665
Published online:Mar 19, 2017
Article type:Research Article
Received:Sep 27, 2016
Accepted:Jan 15, 2017
How to Cite:Hamta A, sahraei M. A single-nucleotide polymorphism of GRIN1 in heroin and methamphetamine addicts at a rehabilitation sanatorium in Markazi province, Iran. J Kermanshah Univ Med Sci. 2017;20(4):e69665. doi: https://doi.org/10.22110/jkums.v20i4.3207

Abstract

Introduction: Using addictive drugs can change the amount of neurotransmitters, especially dopamine and glutamate. Glutamate has been known to trigger the relapse and tendency toward addictive drugs. The glutamate receptor ionotropic NMDA type subunit 1 (GRIN1) contains the single- nucleotide polymorphism C1001G (rs11146020) and encodes N-methyl-D-aspartic acid (NDMA) receptor subunit 1 (NR1). The present study was conducted to investigate the relationship between the rs11146020 polymorphism in GRIN1 and addiction to heroin and methamphetamine.

Methods: The present case-control study recruited 90 male heroin and methamphetamine addicts treated with methadone and 100 healthy men. Genomic DNA was extracted from peripheral blood using Iraizol kits. Four pairs of specific primers were designed using AlleleID 7.5, and the T-ARMS PCR was optimized.

Results: The genotype distribution of GG, GC and CC was respectively found to be 66%, 31% and 3% in the control group and 58%, 31% and 11% in the patient group. The statistical analysis suggested no significant differences between these two groups.

Conclusion: No significant relationships were observed between the C1001G polymorphism in GRIN1 and addiction to heroin and methamphetamine.

Fulltext

References

  • 1.
    The references of this article is available on PDF.

Copyright

© 2017, Journal of Kermanshah University of Medical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

18
May
2019
91912

Effect of rs4680 (Val158Met) Polymorphism of the COMT Gene on Opioid Addiction in an Iranian Population: A Case-Control Study

Fatemeh Dahmardeh,
Alireza Rezaeifar

Dahmardeh F, Rezaeifar A. Effect of rs4680 (Val158Met) Polymorphism of the COMT Gene on Opioid Addiction in an Iranian Population: A Case-Control Study. Gene Cell Tissue. 2019;6(2):e91912. doi: https://doi.org/10.5812/gct.91912

9
Jun
2019

ABCB1 Polymorphisms in High-Dose and Low-Dose Dependent Patients Under Methadone Maintenance Treatment in an Iranian Population

Seyed Vahdat Hamraz,
Seyed Abbas Mousavi,
Asghar Shayannia,
Mehdi Mirzaii

Hamraz SV, Mousavi SA, Shayannia A, Mirzaii M. ABCB1 Polymorphisms in High-Dose and Low-Dose Dependent Patients Under Methadone Maintenance Treatment in an Iranian Population. Iran J Psychiatry Behav Sci. 2019;13(2):e90236. doi: https://doi.org/10.5812/ijpbs.90236

31
Oct
2025
Gene Cell Tissue

Association of GRIA3 (rs12557782) Polymorphism with Interferon Beta Resistance Among Multiple Sclerosis Patients from Qazvin Province, Iran

Magnolia Karimi,
Reza Najafipour,
Mitra Ataei,
Safarali Alizadeh,
Hossein Mozhdehi Panah,
Samira Behroozi
,et al.

Karimi M, Najafipour R, Ataei M, Alizadeh S, Mozhdehi Panah H, et al. Association of GRIA3 (rs12557782) Polymorphism with Interferon Beta Resistance Among Multiple Sclerosis Patients from Qazvin Province, Iran. Gene Cell Tissue. 2025;12(4):e168510. doi: https://doi.org/10.5812/gct-168510

15
Mar
2020
International Journal of High Risk Behaviors and Addiction

Are Dose and Duration of Methamphetamine Abuse Associated with Psychotic Symptoms?

Seyed Alireza Sadjadi,
Amir Rezaei Ardani,
Ali Asadi,
Mahboubeh Eslamzadeh

Sadjadi SA, Rezaei Ardani A, Asadi A, Eslamzadeh M. Are Dose and Duration of Methamphetamine Abuse Associated with Psychotic Symptoms?. Int J High Risk Behav Addict. 2020;9(1):e99574. doi: https://doi.org/10.5812/ijhrba.99574

12
Jun
2019

Concurrent Amphetamine and Methamphetamine Use Among Clients of Opioid Maintenance Treatment Programs in Golestan, Iran

Ahmad Danesh,
Alireza Noroozi

Danesh A, Noroozi A. Concurrent Amphetamine and Methamphetamine Use Among Clients of Opioid Maintenance Treatment Programs in Golestan, Iran. Iran J Psychiatry Behav Sci. 2019;13(2):e74234. doi: https://doi.org/10.5812/ijpbs.74234

Download PDF209.33 KB

Crossmark

Crossmark

Checking

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC